J. Michael Pearson, Valeant Pharmaceuticals chairman & CEO, explains why he decided to pursue Allergan and shares his R&D business model, with CNBC's Kate Kelly. This year we are launching 19 products in the United States, says Pearson.
Wednesday, 23 Apr 2014 | 6:13 AM ET
Chris Caso, Susquehanna Financial Group analyst, shares his outlook on Apple in the second half. Apple needs to show shareholders the next new thing, says Caso.
Wednesday, 23 Apr 2014 | 4:10 AM ET
Fraser Howie, director at Newedge Singapore, says the PMI data reveals China is "in a bit of a rut" and that the government has a "horrible problem" as it can't bring out too much stimulus.